UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000016483 |
|---|---|
| Receipt number | R000019121 |
| Scientific Title | Clinicopathological significance of autophagy in granuloma formation of lung |
| Date of disclosure of the study information | 2015/02/09 |
| Last modified on | 2015/02/09 11:25:21 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clinicopathological significance of autophagy in granuloma formation of lung
Acronym
Autophagy in lung granulomas
Scientific Title
Clinicopathological significance of autophagy in granuloma formation of lung
Scientific Title:Acronym
Autophagy in lung granulomas
Region
| Japan |
Condition
Condition
Granulomatous lung
Classification by specialty
| Medicine in general | Pneumology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Autophagy-related protein expressions and the progression of granulomatous lung
Basic objectives2
Others
Basic objectives -Others
Relationships among autophagy-related proteins
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Increased expression of autophagy-related proteins in the progressed granulomatous lung.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Lung with garnulomas
Key exclusion criteria
lung without granuloma
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoshiki Ishii |
Organization
Dokkyo Medical University School of Medicine
Division name
Department of Pulmonary Medicine and Clinical Immunology
Zip code
Address
880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
TEL
0282-87-2151
ishiiysk@dokkyomed.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yasuo Shimizu |
Organization
Dokkyo Medical University School of Medicine
Division name
Department of Pulmonary Medicine and Clinical Immunology
Zip code
Address
880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
TEL
0282-87-2151
Homepage URL
yasuos-s@dokkyomed.ac.jp
Sponsor or person
Institute
Department of Pulmonary Medicine and Clinical Immunology
Dokkyo Medical University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Department of Pulmonary Medicine and Clinical Immunology
Dokkyo Medical University School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 02 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2015 | Year | 02 | Month | 03 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 02 | Month | 03 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Evaluation for the extent of autophgay-related proteins and the progression of diseases.
Management information
Registered date
| 2015 | Year | 02 | Month | 09 | Day |
Last modified on
| 2015 | Year | 02 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019121
